SCHEMBL23930126

SCHEMBL23930126

CN(Cc1ccc2ncccc2c1)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK1 Q15118 2/20 0.56
▸ USP30 Q70CQ3 1/20 0.53
▸ AGTR2 P50052 1/20 0.50
▸ HDAC3 O15379 2/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ PLK1 P53350 1/20 0.47
▸ ALDH1A1 P00352 4/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ POLB P06746 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ TNF P01375 1/20 0.45
▸ NOD2 Q9HC29 1/20 0.45
▸ NOD1 Q9Y239 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18711465 0.89 USP30 (0.53) PDK1USP30AGTR2HDAC3ALOX15
SCHEMBL18701602 0.85 USP30 (0.51) PDK1USP30AGTR2HDAC3ALOX15
SCHEMBL18583568 0.83 ALDH1A1 (0.51) PDK1USP30HDAC3ALOX15HTT
SCHEMBL30257434 0.82 USP30 (0.48) PDK1USP30AGTR2HDAC3ALOX15
SCHEMBL25560665 0.82 USP30 (0.48) PDK1USP30AGTR2HDAC3ALOX15
SCHEMBL17888451 0.82 PDK1 (0.61) PDK1USP30ALOX15HTTPLK1
SCHEMBL17888442 0.82 ALDH1A1 (0.53) USP30HDAC3HTTALDH1A1RAB9A
SCHEMBL19226500 0.79 PDK1 (0.58) PDK1USP30AGTR2ALOX15HTT
SCHEMBL17886754 0.79 PDK1 (0.58) PDK1USP30ALOX15HTTPLK1
SCHEMBL17886955 0.78 ALDH1A1 (0.49) USP30HTTALDH1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159523-A1 PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF SHENZHEN ZHONGGE BIOLOGICAL TECHNOLOGY CO., LTD. (CN) 2023-05-25 — — US disclosed
EP-4141003-A1 PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF Shenzhen Zhongge Biological Technology Co., Ltd. (CN) 2023-03-01 — — EP disclosed
WO-2021213476-A1 PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF 深圳晶泰科技有限公司 (CN) 2021-10-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159523-A1 PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF NCOA4, CCDC47, CCDC6 PDK1 112/4885USP30 2424/4885AGTR2 4363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback